Matsumoto M - Search Results

1

Von Willebrand factor-cleaving protease activity remains at the intermediate level in thrombotic thrombocytopenic purpura.

Sugimoto T, Saigo K, Shin T, Kaneda Y, Manabe N, Narita H, Wakuya J, Imoto S, Murayama T, Matsumoto M, Fujimura Y, Nishimura R, Koizumi T, Kumagai S. Sugimoto T, et al. Among authors: matsumoto m. Acta Haematol. 2005;113(3):198-203. doi: 10.1159/000084451. Acta Haematol. 2005. PMID: 15870491

2

Von Willebrand factor-cleaving protease and Upshaw-Schulman syndrome.

Fujimura Y, Matsumoto M, Yagi H, Yoshioka A, Matsui T, Titani K. Fujimura Y, et al. Among authors: matsumoto m. Int J Hematol. 2002 Jan;75(1):25-34. doi: 10.1007/BF02981975. Int J Hematol. 2002. PMID: 11843286 Review.

3

Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity.

Mori Y, Wada H, Gabazza EC, Minami N, Nobori T, Shiku H, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y. Mori Y, et al. Among authors: matsumoto m. Transfusion. 2002 May;42(5):572-80. doi: 10.1046/j.1537-2995.2002.00100.x. Transfusion. 2002. PMID: 12084165

4

Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.

Kokame K, Matsumoto M, Soejima K, Yagi H, Ishizashi H, Funato M, Tamai H, Konno M, Kamide K, Kawano Y, Miyata T, Fujimura Y. Kokame K, et al. Among authors: matsumoto m. Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11902-7. doi: 10.1073/pnas.172277399. Epub 2002 Aug 14. Proc Natl Acad Sci U S A. 2002. PMID: 12181489 Free PMC article.

5

Mural thrombus generation in type 2A and 2B von Willebrand disease under flow conditions.

Sugimoto M, Matsui H, Mizuno T, Tsuji S, Miyata S, Matsumoto M, Matsuda M, Fujimura Y, Yoshioka A. Sugimoto M, et al. Among authors: matsumoto m. Blood. 2003 Feb 1;101(3):915-20. doi: 10.1182/blood-2002-03-0944. Epub 2002 Sep 12. Blood. 2003. PMID: 12393671 Free article.

6

Successful treatment of a young infant who developed high-titer inhibitors against VWF-cleaving protease (ADAMTS-13): important discrimination from Upshaw-Schulman syndrome.

Ashida A, Nakamura H, Yoden A, Tamai H, Ishizashi H, Yagi H, Matsumoto M, Fujimura Y. Ashida A, et al. Among authors: matsumoto m. Am J Hematol. 2002 Dec;71(4):318-22. doi: 10.1002/ajh.10228. Am J Hematol. 2002. PMID: 12447964 Free article.

7

Intensive plasma IgG removal therapy for severe thrombotic thrombocytopenic purpura.

Amano SY, Inoue M, Yoshida Y, Yagi H, Ishizashi H, Matsumoto M, Fujimura Y, Yoshioka A. Amano SY, et al. Among authors: matsumoto m. Int J Hematol. 2002 Dec;76(5):474-6. doi: 10.1007/BF02982815. Int J Hematol. 2002. PMID: 12512844 No abstract available.

8

[vWF-cleaving protease/ADAMTS 13].

Matsumoto M, Yagi H, Fujimura Y. Matsumoto M, et al. Rinsho Ketsueki. 2003 Mar;44(3):159-67. Rinsho Ketsueki. 2003. PMID: 12722342 Review. Japanese. No abstract available.

9

ADAMTS-13 cysteine-rich/spacer domains are functionally essential for von Willebrand factor cleavage.

Soejima K, Matsumoto M, Kokame K, Yagi H, Ishizashi H, Maeda H, Nozaki C, Miyata T, Fujimura Y, Nakagaki T. Soejima K, et al. Among authors: matsumoto m. Blood. 2003 Nov 1;102(9):3232-7. doi: 10.1182/blood-2003-03-0908. Epub 2003 Jul 17. Blood. 2003. PMID: 12869506 Free article.

10

VWF73, a region from D1596 to R1668 of von Willebrand factor, provides a minimal substrate for ADAMTS-13.

Kokame K, Matsumoto M, Fujimura Y, Miyata T. Kokame K, et al. Among authors: matsumoto m. Blood. 2004 Jan 15;103(2):607-12. doi: 10.1182/blood-2003-08-2861. Epub 2003 Sep 25. Blood. 2004. PMID: 14512308 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,820 results

Search Page

Filters